Trade GlaxoSmithKline plc - GSK CFD
Add to favourite- Summary
- Historical Data
Spread | 0.11 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 0.1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 40.86 |
Open | 40.92 |
1-Year Change | 11.04% |
Day's Range | 40.92 - 41.25 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 25, 2024 | 40.86 | -0.15 | -0.37% | 41.01 | 41.04 | 40.75 |
Apr 24, 2024 | 40.80 | -0.38 | -0.92% | 41.18 | 41.18 | 40.58 |
Apr 23, 2024 | 41.18 | 0.55 | 1.35% | 40.63 | 41.19 | 40.52 |
Apr 22, 2024 | 40.53 | 0.59 | 1.48% | 39.94 | 40.70 | 39.89 |
Apr 19, 2024 | 39.70 | 0.37 | 0.94% | 39.33 | 39.70 | 39.30 |
Apr 18, 2024 | 39.22 | -0.11 | -0.28% | 39.33 | 39.44 | 39.10 |
Apr 17, 2024 | 39.53 | -0.15 | -0.38% | 39.68 | 39.80 | 39.39 |
Apr 16, 2024 | 39.89 | -0.03 | -0.08% | 39.92 | 40.17 | 39.66 |
Apr 15, 2024 | 40.44 | -0.41 | -1.00% | 40.85 | 41.00 | 40.39 |
Apr 12, 2024 | 40.60 | -0.25 | -0.61% | 40.85 | 40.92 | 40.44 |
Apr 11, 2024 | 40.73 | -0.26 | -0.63% | 40.99 | 41.18 | 40.62 |
Apr 10, 2024 | 40.63 | 0.09 | 0.22% | 40.54 | 40.70 | 40.43 |
Apr 9, 2024 | 40.82 | 0.02 | 0.05% | 40.80 | 40.90 | 40.61 |
Apr 8, 2024 | 40.80 | -0.17 | -0.41% | 40.97 | 41.02 | 40.77 |
Apr 5, 2024 | 41.12 | 0.59 | 1.46% | 40.53 | 41.19 | 40.46 |
Apr 4, 2024 | 40.80 | -0.85 | -2.04% | 41.65 | 41.82 | 40.79 |
Apr 3, 2024 | 41.50 | 0.00 | 0.00% | 41.50 | 41.69 | 41.25 |
Apr 2, 2024 | 41.74 | -0.29 | -0.69% | 42.03 | 42.08 | 41.61 |
Apr 1, 2024 | 42.36 | -0.36 | -0.84% | 42.72 | 42.72 | 42.17 |
Mar 28, 2024 | 42.81 | -0.12 | -0.28% | 42.93 | 43.16 | 42.81 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
GlaxoSmithKline Company profile
About GlaxoSmithKline plc (ADR)
GlaxoSmithKline PLC is a global healthcare company. The Company researches and develops a range of products in three primary areas: Pharmaceuticals, Vaccines and Consumer Healthcare. Its product formulations include tablets, creams/ointments, inhalers, injections, liquids and sterile products. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency virus (HIV), immuno-inflammation and oncology. Its Vaccines business has a portfolio of vaccines to help protect people from a range of diseases throughout their lives. Its vaccines tackle diseases, including pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough and influenza. Its Consumer Healthcare business combines science and consumer insights to create everyday healthcare brands that consumers trust, and experts recommend for oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, GlaxoSmithKline plc (ADR) revenues increased less than 1% to £34.11B. Net income decreased 24% to £4.39B. Revenues reflect Pharmaceuticals segment increase of 4% to £17.73B, US segment increase of 4% to £15.09B, also reflect Consumer Healthcare segment decrease of 4% to £9.61B, Vaccines segment decrease of 3% to £6.78B, Unallocated segment decrease from £28M to £0K.
Equity composition
Ordinary Shs. 25p Par, 05/11, 10B auth., 5,657,488,184 issd., less 494,074,284 Treas. shs. @ Cost. Insiders own 0.02%. PO: NA. 11/91, 9/89, & 2/86,2-for-1 stock splits. 2/00, Company formed through merger with SmithKline Beecham plc @ 1 ADR-for-1.138 ADS of GSK and Glaxo Wellcome plc @ 1.
Industry: | Pharmaceuticals (NEC) |
980 Great West Road
BRENTFORD
MIDDLESEX TW8 9GS
GB
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com